A Malaria Vaccine to Stop Malaria Transmission

Abstract (Set) Malaria is a disease caused by parasites of the genus Plasmodium. It affects near 2 billion people worldwide and results in 1-2 million deaths every year. Transmission-blocking vaccines (TBV) have received attention as potentially effective strategy in the fight against malaria. Surface antigens have been identified as candidates for the development of TBVs. However, efforts to produce properly folded recombinant form of full length of antigens have not been so fruitful. This invention uses a new cloning strategy to obtain the protein in immunologically active conformation, which produced high titer antibodies. These antibodies exhibited nearly complete blocking of malaria transmission when tested in mosquito membrane feeding assay. This invention provides the proof-of-concept that adjuvant formulation can now be developed into a malaria vaccine to stop and/or reduce malaria transmission by vaccination. Description (Set) Proposed Use (Set) Development of malaria transmission-blocking vaccine

Inventor(s): Kumar, Nirbhay ,Angov, Evelina

Type of Offer: Licensing



Next Patent »
« More Medical Patents

Share on      


CrowdSell Your Patent